- Home
- AKRO vs CWEN Comparison
AKRO vs CWEN Comparison
Compare AKRO & CWEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- CWEN
- Stock Information
- Founded
- AKRO 2017
- CWEN 2012
- Country
- AKRO United States
- CWEN United States
- Employees
- AKRO N/A
- CWEN N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- CWEN Electric Utilities: Central
- Sector
- AKRO Health Care
- CWEN Utilities
- Exchange
- AKRO Nasdaq
- CWEN Nasdaq
- Market Cap
- AKRO 2.8B
- CWEN 3.4B
- IPO Year
- AKRO 2019
- CWEN 2013
- Fundamental
- Price
- AKRO $39.85
- CWEN $28.87
- Analyst Decision
- AKRO Strong Buy
- CWEN Strong Buy
- Analyst Count
- AKRO 9
- CWEN 6
- Target Price
- AKRO $76.29
- CWEN $34.33
- AVG Volume (30 Days)
- AKRO 1.1M
- CWEN 874.5K
- Earning Date
- AKRO 05-16-2025
- CWEN 04-30-2025
- Dividend Yield
- AKRO N/A
- CWEN 5.93%
- EPS Growth
- AKRO N/A
- CWEN 20.79
- EPS
- AKRO N/A
- CWEN 0.79
- Revenue
- AKRO N/A
- CWEN $1,406,000,000.00
- Revenue This Year
- AKRO N/A
- CWEN $10.50
- Revenue Next Year
- AKRO N/A
- CWEN $8.32
- P/E Ratio
- AKRO N/A
- CWEN $36.31
- Revenue Growth
- AKRO N/A
- CWEN 9.08
- 52 Week Low
- AKRO $17.86
- CWEN $24.02
- 52 Week High
- AKRO $58.40
- CWEN $31.09
- Technical
- Relative Strength Index (RSI)
- AKRO 44.56
- CWEN 50.91
- Support Level
- AKRO $41.60
- CWEN $28.12
- Resistance Level
- AKRO $46.47
- CWEN $29.06
- Average True Range (ATR)
- AKRO 2.26
- CWEN 0.72
- MACD
- AKRO 0.08
- CWEN -0.01
- Stochastic Oscillator
- AKRO 21.84
- CWEN 48.80
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About CWEN Clearway Energy Inc. Class C
Clearway Energy Inc is a publicly-traded energy infrastructure investor with a focus on investments in clean energy and owner of modern, sustainable and long-term contracted assets across North America. The company segments its operations into Flexible Generation, renewables and Corporate divisions.